Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate powder and solvent for prolonged release suspension for injection)
Agenda - Multi-stakeholder workshop on tailored clinical approach for biosimilars
Ketoprofen: European public maximum-residue-limit assessment report (EPMAR) - CVMP
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 33, Status: Authorised
Quality guidelines
Feedback from European Medicine Agency (EMA) to the EU Commission request to evaluate the feasibility of alternatives to replace titanium dioxide (TiO2) in medicinal products and its possible impact on medicines’ availability
Clinical investigation of medicines for the treatment of Alzheimer's disease - Scientific guideline
Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease
Opinion on medicine for use outside EU: Pyramax, artesunate,pyronaridine, Malaria, 16/02/2012 Positive opinion
Marketing authorisation application (MAA) - pre-submission interactions form